middle.news
Firebrick gains fresh funding for expanding Nasodine pipeline
8:18am on Wednesday 23rd of September, 2026 AEST
•
Healthcare
Read Story
Firebrick gains fresh funding for expanding Nasodine pipeline
8:18am on Wednesday 23rd of September, 2026 AEST
Key Points
$293,000 R&D Tax Incentive payment received
Linked to $673,000 of FY2026 R&D expenditure
Funding supports development of new Nasodine products
No new revenue guidance or commercial agreement disclosed
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Firebrick Pharma (ASX:FRE)
OPEN ARTICLE